Cardiac amyloidosis was once considered a fatal diagnosis. New FDA-approved medications are now helping patients live longer. Here’s what doctors say about symptoms, treatment and early detection.
BACKGROUND: With the increasing diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) at earlier stages and new ...
Temporal trends in mortality from bladder cancer with chronic kidney disease in the United States, 1999–2023: A population-based analysis. This is an ASCO Meeting Abstract from the 2026 ASCO ...
Please provide your email address to receive an email when new articles are posted on . An amyloidosis diagnosis can take upwards of 2 years. Initial symptoms often are nondescript, and irreversible ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results